Immunomodulatory interventions vs placebo
Cognitive effects · people with focal epilepsy
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Findings
What do systematic reviews say?
4,756 questions · 13,493 findings · 1,305 reviews · Headline outcomes only
No studies found 2,594 · 19.2%GRADE not reported 728 · 5.4%Very low 2,868 · 21.3%Low 3,777 · 28%Moderate 2,620 · 19.4%High 906 · 6.7%
Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Immunomodulatory interventions vs placebo
Quality of life · people with focal epilepsy
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Bisphosphonates vs placebo or no treatment
BMD Z score (total hip/femoral neck) · adults with β‐thalassaemia and osteoporosis
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Zinc vs placebo
BMD Z score (total hip/femoral neck) · children and adults with β‐thalassaemia major and low bone mass
Summary of findings – zinc probably leads to higher BMD Z score (total hip/femoral neck) compared with placebo (moderate certainty).
1 finding from 1 review
- MD 0.15 [0.11, 0.19]1 study · 37 participantsModerate
Zinc vs placebo
BMD Z score (lumbar spine) · children and adults with β‐thalassaemia major and low bone mass
Summary of findings – zinc probably leads to higher BMD Z score (lumbar spine) compared with placebo (moderate certainty).
1 finding from 1 review
- MD 0.15 [0.1, 0.2]1 study · 37 participantsModerate
Zinc vs placebo
BMD Z score (wrist) · children and adults with β‐thalassaemia major and low bone mass
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Zinc vs placebo
Incidence of fractures · children and adults with β‐thalassaemia major and low bone mass
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Zinc vs placebo
Mobility · children and adults with β‐thalassaemia major and low bone mass
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Bisphosphonates vs placebo or no treatment
BMD Z score (lumbar spine) · adults with β‐thalassaemia and osteoporosis
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Zinc vs placebo
Quality of life · children and adults with β‐thalassaemia major and low bone mass
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Zinc vs placebo
Adverse effects of treatment · children and adults with β‐thalassaemia major and low bone mass
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Summary of findings – denosumab vs placebo
BMD Z score (total hip/femoral neck) · adults with β‐thalassaemia and low bone mass
Summary of findings – denosumab showed no clear difference in BMD Z score (total hip/femoral neck) compared with placebo (low certainty).
1 finding from 1 review
- MD 0.051 study · 63 participantsLow
Summary of findings – denosumab vs placebo
BMD Z score (lumbar spine) · adults with β‐thalassaemia and low bone mass
Summary of findings – denosumab showed no clear difference in BMD Z score (lumbar spine) compared with placebo (low certainty).
1 finding from 1 review
- no estimate extracted1 study · 63 participantsLow
Summary of findings – denosumab vs placebo
BMD Z score (wrist) · adults with β‐thalassaemia and low bone mass
Summary of findings – denosumab showed no clear difference in BMD Z score (wrist) compared with placebo (low certainty).
1 finding from 1 review
- no estimate extracted1 study · 63 participantsLow
Summary of findings – denosumab vs placebo
Incidence of fractures · adults with β‐thalassaemia and low bone mass
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Summary of findings – denosumab vs placebo
Mobility · adults with β‐thalassaemia and low bone mass
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Summary of findings – denosumab vs placebo
Quality of life · adults with β‐thalassaemia and low bone mass
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Summary of findings – denosumab vs placebo
Adverse effects of treatment · adults with β‐thalassaemia and low bone mass
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Summary of findings – strontium ranelate vs placebo
BMD Z score (total hip/femoral neck) · women with low bone mass and β‐thalassaemia
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Bisphosphonates vs placebo or no treatment
BMD Z score (wrist) · adults with β‐thalassaemia and osteoporosis
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found